Results for chronic disease code G13 - Myasthenia gravis

Chemical substance: rozanolixizumab

ATC code: L04AL02 • Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Neonatal fragment crystallizable receptor (fcrn) inhibitors

Chemical substance: efgartigimod alfa

ATC code: L04AA58 • Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants

Chemical substance: neostigmine bromide

ATC code: N07AA01 • Nervous system | Parasympathomimetics | Anticholinesterases

Chemical substance: azathioprine

ATC code: L04AX01 • Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Other immunosuppressants

Chemical substance: pyridostigmine bromide

ATC code: N07AA02 • Nervous system | Parasympathomimetics | Anticholinesterases

Chemical substance: prednisone

ATC code: H02AB07 • Systemic hormonal preparations, excluding sex hormones and insulins | Corticosteroids for systemic use | Corticosteroids for systemic use, plain | Glucocorticoids

Chemical substance: prednisone

ATC code: H02AB07 • Systemic hormonal preparations, excluding sex hormones and insulins | Corticosteroids for systemic use | Corticosteroids for systemic use, plain | Glucocorticoids

Chemical substance: prednisone

ATC code: H02AB07 • Systemic hormonal preparations, excluding sex hormones and insulins | Corticosteroids for systemic use | Corticosteroids for systemic use, plain | Glucocorticoids

Chemical substance: prednisone

ATC code: H02AB07 • Systemic hormonal preparations, excluding sex hormones and insulins | Corticosteroids for systemic use | Corticosteroids for systemic use, plain | Glucocorticoids